Mounjaro and Fasting Blood Tests: When and How to Plan

Mounjaro is a prescription medicine, not a substance routine blood tests screen for, so it does not 'show up' as itself. It can affect some results: it lowers blood glucose, and the SmPC notes it can raise pancreatic amylase and lipase. A fasting blood test means not eating beforehand, not stopping your weekly injection, so keep taking Mounjaro as normal unless told otherwise. Tell the person taking your blood that you use it.

A common question is whether Mounjaro 'shows up' on a blood test, and whether you need to do anything special, such as stopping it, before a fasting test. The short answers are reassuring: it is not something routine tests look for, and a fasting test is about not eating, not about pausing your weekly injection.

This guide explains whether Mounjaro shows up on a blood test, the results it can affect, whether to fast or pause it, and what to tell the person taking your blood. It draws on the UK Summary of Product Characteristics and the NHS. It is general information; follow any specific instructions from whoever requested your test.

Does Mounjaro show up on a blood test?

Not as itself. Mounjaro (tirzepatide) is a prescription medicine, and routine blood tests are not designed to detect it, so it does not 'show up' the way the question often imagines ¹. A standard blood test is not a drug screen looking for your prescribed medicines ¹.

What a blood test can show is the effects of the medicine on certain measurements, which is a different thing from detecting the drug itself ¹. The next section covers which results those are ¹.

So if your worry is that a blood test will somehow reveal that you take Mounjaro as a hidden finding, that is not how it works; but it is worth knowing the effects it can have on results, and simply telling the person taking your blood that you take it ¹².

It is worth distinguishing two different questions people are really asking with this search ¹. One is whether a test can detect the drug as a substance, like a drug screen, and the answer is that routine blood tests are not looking for prescribed medicines in that way ¹. The other is whether taking the medicine changes any of the numbers a test reports, and there the answer is yes for a few specific results, which is the genuinely useful part to understand and the focus of the rest of this guide ¹.

Results Mounjaro can affect

The medicine can affect a few results. Most obviously, it lowers blood glucose, which is part of how it works, so a glucose or HbA1c result reflects that effect, especially in people with diabetes ¹. That is an expected, intended effect rather than a problem ¹.

The SmPC also notes that tirzepatide can raise pancreatic amylase and lipase, enzymes sometimes measured in blood tests, with mean increases reported in the trials ¹. So these can read higher on the medicine ¹.

Importantly, the SmPC is clear that raised amylase or lipase alone is not predictive of pancreatitis in the absence of other signs and symptoms ¹. So a mildly raised result without symptoms is interpreted in context, which is one reason telling the requesting clinician you take the medicine helps ¹.

These effects on results are worth knowing about precisely so they do not catch you off guard ¹. A glucose reading that is lower than before, or a pancreatic enzyme that reads above the usual range, can look surprising if you do not realise the medicine can produce them, but both are recognised in the SmPC ¹. Understanding them in advance turns a potentially worrying result into an expected one that your clinician can interpret sensibly ¹².

Fasting blood tests: do you stop Mounjaro?

This is the key practical point. A fasting blood test means not eating for a set period beforehand (and usually only drinking water), so the result is not affected by a recent meal ¹. Fasting is about food, not about your medicines ¹.

So a fasting blood test does not mean stopping your Mounjaro: it is a weekly injection, not a daily tablet taken with food, and you keep taking it on your normal schedule unless the person who requested the test specifically tells you otherwise ¹². Do not skip a dose for a blood test on your own assumption ².

If you are unsure whether to fast, for how long, or whether any specific instruction applies to your medicines, ask whoever requested the test; the fasting instruction comes from them ². Our guide on the missed-dose rule covers why you should not casually skip doses.

There is an important exception worth flagging for people with diabetes: if you take Mounjaro alongside insulin or a sulphonylurea, the question of whether and how to adjust those other medicines around a fasting test is a real one, because fasting affects blood sugar ¹². But that is about the diabetes medicines and the fasting, not about the Mounjaro injection itself, and it is something to clarify with the clinician who manages your diabetes rather than to improvise ². For Mounjaro alone, in someone without diabetes, a fasting test changes nothing about the weekly injection ¹.

Considering treatment for weight management? You can start an assessment with a Cloud Pharmacy clinician, who will review your medical history and confirm whether treatment is appropriate.

What to tell the person taking your blood

As good practice, tell the person taking your blood, or the clinician who requested the test, that you take tirzepatide (Mounjaro)². This lets them interpret results like glucose, amylase and lipase in the right context ¹².

If you have diabetes and take Mounjaro alongside other glucose-lowering medicines, mention that too, since it is relevant to interpreting glucose results and any fasting ¹². There is no need to volunteer it as a confession; it is simply useful clinical information ².

Knowing you take the medicine helps avoid a raised amylase or lipase being misread, since the SmPC notes these can rise on treatment and are not, alone, a sign of pancreatitis ¹. Context makes the results more meaningful ¹.

In practice, this often happens naturally through your records, but it is worth not relying on that alone ². The person taking your blood may not be the one who interprets it, and a result can be reviewed by someone who does not have your full medication history in front of them ². A simple mention, or making sure your medicines are up to date on any form you complete, closes that gap and means the result is read with the right context from the start ¹².

Pancreatic enzymes and context

Because amylase and lipase can be raised by the medicine, it is worth understanding how that is interpreted. The SmPC reports mean increases in these pancreatic enzymes on tirzepatide, but states their clinical significance is unknown in the absence of other signs and symptoms of pancreatitis¹. So a raised level is not automatically alarming ¹.

What would matter is a raised enzyme level together with symptoms, in particular severe, persistent abdominal pain, which is the red flag for acute pancreatitis that needs immediate medical attention ¹. The blood result alone, without symptoms, is interpreted cautiously ¹.

So if a routine test shows a mildly raised amylase or lipase and you feel well, that is context your clinician weighs rather than a cause for panic, and knowing you take Mounjaro is part of that context ¹².

This is a good example of why telling the requesting clinician you take the medicine is more than a formality ¹. A raised pancreatic enzyme result seen in isolation, without the knowledge that you are on a GLP-1 medicine, could prompt more concern or investigation than the situation warrants ¹. With that context, the same result is interpreted sensibly, alongside whether you have any symptoms, which is exactly how the SmPC frames it ¹. The result is a piece of information to interpret, not a verdict on its own, and that is especially true when the medicine is part of the context ¹.

Practical planning

Putting it together: for any blood test, keep taking Mounjaro on your normal weekly schedule unless specifically told otherwise, follow any fasting-from-food instruction from whoever requested the test, and tell the person taking your blood that you use the medicine ¹². That covers the vast majority of situations ².

There is no medicine-related reason to time a blood test around your injection day, since the test is not detecting the drug ¹. If a specific test needs special preparation, those instructions come from the requesting clinician, not from the medicine itself ².

Our guide on how Mounjaro works covers the medicine more broadly. For blood tests, the headline is that it does not show up as a substance, it can affect glucose, amylase and lipase, fasting means not eating rather than stopping the injection, and telling the person taking your blood helps ¹².

The most common mistake this guide is meant to head off is someone skipping their weekly injection because they have a fasting blood test, on the assumption that fasting means going without all medicines ¹². It does not: fasting is about food and most drinks other than water, and your weekly Mounjaro continues as normal unless the requesting clinician specifically says otherwise ¹². Skipping a dose unnecessarily just disrupts your treatment for no benefit, which is exactly the sort of well-meant but unhelpful step worth avoiding ¹.

Frequently asked questions

Does Mounjaro show up on a blood test?

Not as itself. Mounjaro is a prescription medicine, and routine blood tests are not designed to detect it, so it does not show up the way the question often imagines ¹. What a test can show is its effects, such as lower glucose and sometimes raised pancreatic amylase and lipase ¹.

Do I need to stop Mounjaro before a fasting blood test?

No. A fasting blood test means not eating beforehand, not stopping your medicines, and Mounjaro is a weekly injection rather than a tablet taken with food ¹. Keep taking it on your normal schedule unless the person who requested the test specifically tells you otherwise ¹².

What blood results does Mounjaro affect?

It lowers blood glucose as part of how it works, so glucose and HbA1c reflect that, and the SmPC notes it can raise pancreatic amylase and lipase ¹. Raised amylase or lipase alone, without symptoms, is not predictive of pancreatitis, which is why context matters ¹.

Should I tell the person taking my blood that I take Mounjaro?

Yes, as good practice. Telling them, or the clinician who requested the test, that you take tirzepatide (Mounjaro) lets them interpret results like glucose, amylase and lipase in context ¹². If you have diabetes, mention that too ².

Is a raised amylase or lipase on Mounjaro a sign of pancreatitis?

Not by itself. The SmPC says raised pancreatic amylase or lipase alone is not predictive of pancreatitis in the absence of other signs and symptoms ¹. What matters is a raised level together with symptoms like severe, persistent abdominal pain, which needs immediate medical attention ¹.

Do I need to time a blood test around my Mounjaro injection?

No. The test is not detecting the medicine, so there is no medicine-related reason to coordinate a blood test with your injection day ¹. Any special preparation for a specific test comes from the requesting clinician, not from the medicine ².

Your next step

Mounjaro is a prescription medicine, not a substance routine blood tests screen for, so it does not show up as itself. It can affect some results, lowering blood glucose and sometimes raising pancreatic amylase and lipase, though raised enzymes alone without symptoms are not a sign of pancreatitis. A fasting blood test means not eating beforehand, not stopping your weekly injection.

Keep taking Mounjaro on your normal schedule unless specifically told otherwise, follow any fasting-from-food instruction from whoever requested the test, and tell the person taking your blood that you use it so results are read in context. There is no medicine-related reason to time a test around your injection day, and a fasting test is no reason to skip your weekly injection unless you have specifically been told otherwise.

Disclaimer

This guide is for general information only and does not constitute medical advice, diagnosis or treatment. The information here describes general clinical context based on UK regulatory sources cited above; it is not a recommendation for any specific medicine or treatment, which can only be made by a prescriber following individual assessment.

If you are considering treatment, speak to your GP or pharmacist, or arrange a consultation with a Cloud Pharmacy clinician. Prescription-only medicines are issued only after clinical assessment and where appropriate.

If you experience side effects from any medicine, you can report them through the Yellow Card scheme at yellowcard.mhra.gov.uk.

References

1. 4.8 Undesirable effects (increased amylase/lipase; clinical significance unknown without other pancreatitis signs) and 5.1 (lowers blood glucose); 4.4 (pancreatitis red flag: severe persistent abdominal pain)
2. Tirzepatide (tell about all medicines; do not stop without advice)